A University of Dundee spin-out has received investment to commercialise the human skin culture system it developed to provide an alternative to animal testing.
This will enable the company to continue the roll-out of its service business, develop further product offerings, and back its initial launch in the US, where the majority of potential customers are based.
Ten Bio is headquartered in Dundee and is opening a laboratory in Kannapolis, North Carolina.
Its research and product development programmes have already recieved grant funding provided by Innovate UK.
Founders Dr Robyn Hickerson and Dr Michael Conneely were initially developing explant skin models to enable their drug discovery programmes when they created the company.
Building on years of research, they created a patented a human skin culture system that closely mimics intact, living skin.
TenSkin stretches human skin to an optimal tension to mimic the mechanobiology that exists in the actual skin on our bodies.
Moray Martin, chief executive at TRICAP, said: “Ten Bio’s in vitro science and technology offers a reliable and credible alternative to some usage of animal testing and thus a more accurate testing of products en route to market for both pharma/biotech and cosmetic companies.
“This is an innovative company with an exciting commercial future that we are honoured to be sharing with them.”
Ten Bio was one of the winners of last year’s Scottish EDGE competition, and Dr Hickerson was runner-up in the Converge Challenge category of Converge 2020 – a company creation programme designed for staff, students and graduates of universities in Scotland.
Don’t miss the latest headlines with our twice-daily newsletter – sign up here for free.